Aebli N, Reichen J
Institut für Klinische Pharmakologie, Universität Bern.
Schweiz Med Wochenschr. 1991 Jun 29;121(26):970-6.
The prognostic value of different conventional liver tests was compared with that of the galactose elimination capacity (GEC) in 37 patients with chronic active hepatitis. During a mean observation period of 4.5 years, 12 patients died of the disease. None of the conventional liver tests (transaminases, prothrombin time, albumin, Child-Pugh classification) discriminated between survivors and nonsurvivors. In contrast, GEC discriminated between survivors and nonsurvivors (p less than 0.04). The best prognostic criterion was a decrease in GEC, since only patients with a decrease died of the disease. The positive and negative predictive values of this criterion were 100 and 60% respectively. This concept could prove useful for stratification purposes in therapeutic trials, as well as in assessment of novel forms of treatment of chronic active hepatitis.
在37例慢性活动性肝炎患者中,比较了不同传统肝功能检查与半乳糖清除能力(GEC)的预后价值。在平均4.5年的观察期内,12例患者死于该疾病。没有一项传统肝功能检查(转氨酶、凝血酶原时间、白蛋白、Child-Pugh分级)能够区分存活者和非存活者。相比之下,GEC能够区分存活者和非存活者(p<0.04)。最佳预后标准是GEC降低,因为只有GEC降低的患者死于该疾病。该标准的阳性和阴性预测值分别为100%和60%。这一概念可能在治疗试验的分层以及慢性活动性肝炎新治疗方法的评估中被证明是有用的。